(FM) Oncología
Departamento académico
Centre Hospitalier Regional et Universitaire de Lille
Lila, FranciaPublikationen in Zusammenarbeit mit Forschern von Centre Hospitalier Regional et Universitaire de Lille (1)
2022
-
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial
European Journal of Cancer, Vol. 174, pp. 221-231